What compounded GLP-1s cost, and why they were cheaper

Compounded GLP-1s undercut the branded products by a large margin for two or three years, and that price gap is the entire reason the category exists. In 2026 the gap narrowed sharply, and for some people it closed completely. If you chose compounded on price, the arithmetic you used is probably out of date.

Why compounded was cheaper

Three reasons, and only one of them is about the pharmacy being efficient.

No development cost. The company that develops a drug pays for the clinical trials and the approval process. A compounder does not. Those costs are real and enormous, and they are baked into the branded price.

No FDA review. This is the same fact stated as a cost saving. A compounded product is not reviewed for safety, effectiveness or manufacturing quality before it reaches you. Removing a step removes its cost.

Outside the insurance system. Branded drug pricing runs through a chain of list prices, rebates and pharmacy benefit managers. Compounded products sold direct for cash skip all of it.

So the discount was not a trick. It was real, and it came with a real trade off that a lot of marketing worked hard not to mention.

What changed in 2026

Two federal moves reset the floor.

The Medicare GLP-1 Bridge. A time limited demonstration from CMS running 1 July 2026 to 31 December 2027, giving eligible Medicare Part D beneficiaries certain GLP-1 drugs for fifty dollars a month. The named products are Foundayo, Wegovy in injection and tablet form, and Zepbound KwikPen.

There is fine print, and almost nobody prints it. The Part D deductible does not apply. The fifty dollars does not count toward your true out of pocket total. There is no low income subsidy attached to it. And it operates outside the normal Part D benefit flow, so your plan is not carrying the risk.

A federal direct purchasing channel. Launched in early 2026 following pricing agreements with the manufacturers, offering the approved products at substantially reduced cash prices. It is not a pharmacy. You need a valid prescription already, and you use a coupon at a participating pharmacy. It also excludes controlled substances and drugs carrying certain federal safety programmes, which does not affect GLP-1s but does affect other categories people ask about.

And from 2027, a successor programme called BALANCE will let state Medicaid agencies and Medicare Part D plans opt into negotiated GLP-1 pricing, with participating Part D plans capping patient cost at fifty dollars per monthly supply in the initial coverage phase.

The four routes, plainly

There are now at least four ways to pay for a GLP-1, and the cheapest depends entirely on who you are.

1. Commercial insurance. If your plan covers weight management drugs, this is often cheapest. Many plans still do not cover them, or require prior authorisation.
2. Medicare. If you are a Part D beneficiary, check whether the GLP-1 Bridge covers you. Fifty dollars a month, with the fine print above.
3. Federal cash pricing. For people without coverage, the reduced cash prices are far below what the same products cost in 2025.
4. Compounded. Still generally the lowest sticker price, and the only one of the four that is not an FDA approved product.

How to actually compare

Compare the total annual cost, not the monthly sticker. Ask each route:

• What is the monthly cost at my dose, not the starting dose?
• Does the price change when I titrate up?
• Is there a membership, consultation or subscription fee on top of the medication?
• What happens to the price after any introductory period?
• What is the cancellation process, and how easy is it?

That last one matters more than people expect. Subscription telehealth billing has been the subject of federal enforcement, including a Federal Trade Commission order in December 2025 requiring a telehealth weight loss provider to disclose refund and cancellation terms before taking payment and to honour cancellation requests promptly.

The honest summary

Compounded GLP-1s were cheaper for structural reasons, not because someone found a clever loophole in manufacturing. The saving was real and so was the trade off.

What is different now is that the trade off buys you less than it used to. The approved products are no longer priced at a level only insurance can reach. Before your next refill, it is worth spending twenty minutes checking what the reviewed version would actually cost you.

What to ask

• What is my total cost per month at my target dose, including any fees?
• Am I eligible for the Medicare GLP-1 Bridge?
• What would the approved product cost me through my insurance, with prior authorisation?
• What would it cost me through federal cash pricing?
• How do I cancel, and how quickly does that take effect?

Sources

• Centers for Medicare and Medicaid Services, Medicare GLP-1 Bridge
• Centers for Medicare and Medicaid Services, BALANCE Model
• The White House, fact sheet on the launch of the federal direct purchasing channel, February 2026
• Federal Trade Commission, final order concerning a telehealth provider and GLP-1 weight loss advertising, December 2025
• Federal Food, Drug, and Cosmetic Act sections 503A and 503B, 21 U.S.C. 353a and 353b

How we verify: see /how-we-verify.

Keep reading

Whether you can still get compounded semaglutide at all, at /guides/can-i-still-get-compounded-semaglutide.

What the one comparison study found about results, at /guides/does-compounded-semaglutide-work.